GSK To Sell One-Third Of Its UK R&D Site For £400M
GlaxoSmithKline plc (NYSE:GSK) is planning to sell more than one-third of its 92-acre R&D site in Stevenage, the U.K. The Company…
Moderna Is Now More Valued Than Gilead, GlaxoSmithKline: How Long Did COVID-19 Vaccine Maker Take To Hit $100B?
Moderna Inc (NASDAQ: MRNA) stock is on a roll, with its vaccine-induced momentum spilling over into 2021.
The Past Week’s Notable Insider Buys Include Krispy Kreme, Biotechs, SPACs And More
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs.
Initial and secondary public offerings enticed insiders to come out and buy shares this past week.
Besides IPOs, biotechs and special purpose acquisition companies are well represented on this week's list.
The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix
Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow.
Sanofi, GSK Get Nod For Late-Stage COVID-19 Vaccine Trial In India
Sanofi SA (NASDAQ:SNY) and GlaxoSmithKline Plc (NYSE:GSK) have received approval from the Drug Controller General of India (DCGI) for a late-stage clinical trial…
Codexis Says Earns Milestone Payment From GlaxoSmithKline
Codexis, Inc. (NASDAQ:CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, announced it earned a significant milestone payment related to the licensing of its proprietary
COVID-19 Vaccine-Induced Blood Clots Probably Linked To Amino Acids, Study Shows: WSJ
Researchers have pointed a handful of amino acids targeted by key antibodies of some people who received the AstraZeneca…
Nvidia Launches Supercomputer To Help Advance Fields Of Digital Biology, Genomics
Chip supplier Nvidia Corp (NASDAQ: NVDA) on Tuesday launched Cambridge-1, which it claims is the fastest supercomputer in the United Kingdom, dedicated to the healthcare industry.